Editorial: Skin Autoimmunity
暂无分享,去创建一个
[1] H. Nizze,et al. Impact of diet and genes on murine autoimmune pancreatitis , 2020, Journal of cellular and molecular medicine.
[2] K. Kähler,et al. Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma – an update , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[3] K. Asadullah,et al. Cytokines of the IL‐17 family in psoriasis , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[4] R. Ludwig,et al. Drug Development in Pemphigoid Diseases , 2020, Acta dermato-venereologica.
[5] S. Pasoto,et al. Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity , 2019, Arthritis Research & Therapy.
[6] J. Fairley,et al. The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid , 2019, Front. Immunol..
[7] W. Sondermann,et al. Dermatological complications of therapy with biologics in inflammatory autoimmune diseases , 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[8] T. Mayadas,et al. Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line , 2019, Nature Communications.
[9] E. Schmidt,et al. Pemphigus , 2019, The Lancet.
[10] C. Probst,et al. Serological Diagnosis of Autoimmune Bullous Skin Diseases , 2019, Front. Immunol..
[11] M. Seelen,et al. Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review , 2019, Front. Immunol..
[12] E. Papakonstantinou,et al. Neurological disorders are associated with bullous pemphigoid , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.
[13] Y. Fujisawa,et al. Possible involvement of IgE antibody in epidermolysis bullosa acquisita: detection and correlation , 2019, European Journal of Dermatology.
[14] H. Shimizu,et al. BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer's Disease than in Bullous Pemphigoid. , 2019, The Journal of investigative dermatology.
[15] S. Finzel,et al. Skin inflammation associated with arthritis, synovitis and enthesitis. Part 2: rheumatoid arthritis, reactive arthritis, Reiter's syndrome, Lyme borreliosis, dermatomyositis and lupus erythematosus , 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[16] H. Busch,et al. IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. , 2019, Journal of autoimmunity.
[17] R. Eming,et al. Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference , 2018, Front. Med..
[18] D. Zillikens,et al. Diagnosis of Autoimmune Blistering Diseases , 2018, Front. Med..
[19] K. Kridin,et al. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations , 2018, Front. Med..
[20] A. Sinha,et al. The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis” , 2018, Front. Med..
[21] M. Schön,et al. The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis , 2018, Front. Immunol..
[22] R. Pollmann,et al. TH1/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus. , 2018, The Journal of allergy and clinical immunology.
[23] James J. Lee,et al. Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid. , 2017, The Journal of investigative dermatology.
[24] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[25] J. Kaffenberger,et al. The association between bullous pemphigoid and neurological disorders: a systematic review , 2017, European Journal of Dermatology.
[26] James T. Elder,et al. Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling , 2017, Human molecular genetics.
[27] K. Papp,et al. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial , 2017, The Lancet.
[28] A. Verkman,et al. Mechanisms of Autoantibody-Induced Pathology , 2017, Front. Immunol..
[29] L. Misery,et al. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial , 2017, The Lancet.
[30] S. Ogston,et al. HLA‐Cw6‐positive patients with psoriasis show improved response to methotrexate treatment , 2017, Clinical and experimental dermatology.
[31] D. Zillikens,et al. Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment , 2016, Molecular medicine.
[32] H. Nakagawa,et al. The first trial of CIM331, a humanized antihuman interleukin‐31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double‐blind, placebo‐controlled study , 2016, The British journal of dermatology.
[33] E. R. Sutherland,et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial , 2016, The Lancet.
[34] S. Krebs,et al. Melanocyte antigen triggers autoimmunity in human psoriasis , 2015, The Journal of experimental medicine.
[35] D. Zillikens,et al. Caspase-1–Independent IL-1 Release Mediates Blister Formation in Autoantibody-Induced Tissue Injury through Modulation of Endothelial Adhesion Molecules , 2015, The Journal of Immunology.
[36] B. Marinari,et al. The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis , 2014, Nature Communications.
[37] A. Christiano,et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition , 2014, Nature Medicine.
[38] C. Rajkumar. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial , 2013 .
[39] D. Zillikens,et al. Pemphigoid diseases , 2013, The Lancet.
[40] S. Ständer,et al. [Chronic pruritus in autoimmune dermatoses : results of a comparative survey]. , 2012, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[41] R. Valenta,et al. The role of T‐cell reactivity towards the autoantigen α‐NAC in atopic dermatitis , 2011, The British journal of dermatology.
[42] R. Ludwig,et al. Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis? , 2009, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.
[43] C. Herzog,et al. Psoriasis: a possible risk factor for development of coronary artery calcification , 2007, The British journal of dermatology.
[44] Daniel B. Shin,et al. Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.
[45] L. Vaillant,et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. , 2002, The New England journal of medicine.
[46] C Bona,et al. Defining criteria for autoimmune diseases (Witebsky's postulates revisited) , 1993, Immunology today.
[47] P. Calabresi,et al. Occlusive vascular disease in psoriatic patients. , 1973, The New England journal of medicine.
[48] J. Silverberg,et al. Phase 2b Randomized Study of Nemolizumab in Adults with Moderate-Severe Atopic Dermatitis and Severe Pruritus. , 2019, The Journal of allergy and clinical immunology.
[49] L. Marshall,et al. Pemphigus , 2017, Nature Reviews Disease Primers.